Quintrio
Home

Stock overview

Fangdd Network Group Ltd. Class A Ordinary Shares

DUO

Fangdd Network Group Ltd is an investment holding company. It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China. All revenues of the Group are derived from the PRC.

Last trade $0.00
Day change $0.00 (0.00%)
Day range $0.495 – $0.56
Volume 19,228
Market cap $22M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

No ratio data was found for DUO.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

No quarterly income statement data was found for DUO.

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
GlobeNewswire Inc.

FangDD Announces Pricing of US$5.0 Million Registered Direct Offering

Fangdd Network Group Ltd. (Nasdaq: DUO), a customer-oriented property technology company in China, announced a registered direct offering of up to 3,125,000 Class A ordinary shares or pre-funded warrants at a price of $1.60 per share. The company intends to use the net proceeds for general corporate purposes.

GlobeNewswire Inc.

FangDD Files 2023 Annual Report on Form 20-F

SHENZHEN, China, April 19, 2024 (GLOBE NEWSWIRE) -- Fangdd Network Group Ltd. (NASDAQ: DUO) (“FangDD” or the “Company”), a customer-oriented property technology company in China, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 with the U.S. Securities and Exchange Commission on April 19, 2024. The annual report can be accessed on the Company’s website at http://ir.fangdd.com. The Company will provide a hard copy of the annual report containing its audited consolidated financial statements, free of charge, to its shareholders and holders of American depositary shares upon request.

Benzinga

Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24 insurance revenue guidance. Clover Health Investments reported quarterly sales of $510.3 million which beat the analyst consensus estimate of $480.25 million by 6.26% and represents a 43.22% decrease over sales of $898.79 million the same period last year. Clover Health Investments shares climbed 11.2% to $0.8537 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers Gaxos.ai Inc. (NASDAQ: GXAI) shares jumped 128.9% to $12.18 after the company announced it acquired the rights to use certain AI-enabled technology from Ultiself. Veritone, Inc. (NASDAQ: VERI) gained 52.4% to $2.6076 following strong sales results. NuCana plc (NASDAQ: NCNA) gained 50.2% to $0.5869 after the company was granted a US Patent for "Phosphoramidate Derivatives For Use In The Treatment Of Cancer; Especially In The Treatment Where The Patient Shows Resistance." The Beauty Health Company (NASDAQ: SKIN) rose 31.9% to $4.7350 after the company reported better-than-expected fourth-quarter revenue results. Arq, Inc. (NASDAQ: ARQ) gained 28.3% to $4.4522 after the company reported upbeat fourth-quarter results. MicroCloud Hologram Inc. (NASDAQ: HOLO) jumped 26.6% to $6.19. Kintara Therapeutics, Inc. (NASDAQ: KTRA) shares gained 26.2% to $0.1055. Nature's Sunshine Products, Inc. (NASDAQ: NATR) jumped 24.7% to $21.47 after the company reported better-than-expected fourth-quarter adjusted EPS results and issued FY24 net sales guidance. Heron Therapeutics, Inc. (NASDAQ: HRTX) gained 24.7% to $2.9428 after the company reported better-than-expected fourth-quarter adjusted EPS results and issued FY24 revenue guidance. Also, Needham maintained a Buy rating on the stock and raised its price target from $4 to $5. Li-Cycle Holdings Corp. (NASDAQ: LICY) shares gained 23.2% to $0.7233. Li-Cycle shares jumped 46% on Tuesday after the ...

Benzinga

Dow Turns Higher; GDS Holdings Shares Climb

U.S. stocks traded mixed toward the end of trading, with the Dow Jones index turning higher on Monday. The Dow traded up 0.08% to 38,753.49 while the NASDAQ fell 0.20% to 16,052.34. The S&P 500 also fell, dropping, 0.14% to 5,116.66. Check This Out: Cramer Says This Healthcare Stock Can Go Higher, Calls Manhattan Associates 'A Winner'   Leading and Lagging Sectors   Materials shares jumped by 0.9% on Monday. In trading on Monday, industrials shares fell by 0.8%.   Top Headline   EQT Corporation (NYSE: EQT) announced that it entered into a definitive merger agreement to acquire Equitrans Midstream Corporation (NYSE: ETRN).   Equities Trading UP   GDS Holdings Limited (NASDAQ: GDS) shares shot up 22% to $7.80 following a report suggesting Hillhouse and Boyu are in talks to invest in the company's Southeast Asia data center business. Shares of Fangdd Network Group Ltd. (NASDAQ: DUO) got a boost, surging 20% to $0.7234 after the company ...

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Jun 9, 20251-for-16reverse split
Aug 4, 20231-for-15reverse split
Jun 7, 20221-for-15reverse split